← Back
$BBNX All transactions

Beta Bionics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$4K

Shares

353

Price

$12

Filed

Mar 5

Insider

Name

Hopman Mark

Title

Chief Commercial Officer

CIK

0002048497

Roles

Officer

Transaction Details

Transaction Date

2026-03-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

139,133

Footnotes

Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.

Filing Info

Accession No.

0002048497-26-000002

Form Type

4

Issuer CIK

0001674632

Hopman Mark's History

Date Ticker Type Value
2026-03-04 BBNX $4K
2026-03-02 BBNX $10K
2026-02-27 BBNX A $0
2026-02-27 BBNX A $0
2026-02-27 BBNX A $0
2025-12-04 BBNX $63K
2025-12-02 BBNX $25K
2025-09-05 BBNX M $58K
2025-09-05 BBNX $235K
2025-09-05 BBNX M $0

Other Insiders at BBNX (90d)

Insider Bought Sold Last
Hopman Mark
Chief Commercial Officer
$99K 2026-03-02
Mensinger Mike
Chief Product Officer
$13K 2026-03-02
Feider Stephen
Chief Financial Officer
$18K 2026-03-02
Saint Sean
President & CEO
$42K 2026-03-02
Russell Steven Jon
Chief Medical Officer
$43K 2026-03-02